Sonnet BioTherapeutics Holdings OverviewSonnet BioTherapeutics Holdings Net Income
Profitability analysis for SONN.
Quarterly Net Income
-$5.69M
↓ 81.71% YoY
As of Sep 2025
Annual Net Income (TTM)
-$16.11M
↓ 116.65% YoY
Trailing 12 months ending Sep 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...